Literature DB >> 7886593

Hypercoagulation in diabetes mellitus.

N Acang1, F D Jalil.   

Abstract

The pathogenesis of diabetic vascular disease is not completely known. Many authors have suggested that hemorheological disturbance is an important factor in the development of vascular complication. The hypercoagulable state also suggested to cause this complication. In order to assess the role of blood coagulation in diabetic patients, we investigated hypercoagulation in diabetic patients and its relation with duration of the disease, smoking habits, blood pressure, blood glucose, diabetic retinopathy, diabetic ulcers and patient treatment. A case control study was done to evaluate these factors in 60 diabetic patients in out-and in-patient clinics of the Department of Internal Medicine, General Hospital Dr M Jamil Padang, during December 1990-March 1991. The average age was 51.55 years, average duration of the disease 5, 8 years. Fibrinogen levels is higher in diabetic patient (mean +/- SD = 442.42 +/- 86.79 mg/dl), compared to normal person (mean +/- SD = 349.2 +/- 35.26 mg/dl), PT is shorter (mean +/- SD = 10.1 +/- 1.31 sec), compared to normal person (mean +/- SD = 11.04 +/- 0.93 sec), APTT is also shorter (mean +/- SD = 29.2 +/- 3.69 sec), compared to normal person (mean +/- SD = 32.16 +/- 3.77 sec). There was a significantly high fibrinogen and short PT and APTT in diabetic patients, especially those who suffered from diabetes for a long time and followed by chronic complications.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7886593

Source DB:  PubMed          Journal:  Southeast Asian J Trop Med Public Health        ISSN: 0125-1562            Impact factor:   0.267


  7 in total

1.  Effects of warfarin and L-carnitine on hemostatic function and oxidative stress in streptozotocin-induced diabetic rats.

Authors:  Ahmed A ElGendy; Amr M Abbas
Journal:  J Physiol Biochem       Date:  2014-03-27       Impact factor: 4.158

2.  Prothrombin time, activated partial thromboplastin time and platelet counts of type II diabetes mellitus: a comparative study.

Authors:  Yitayal Amogne Ambelu; Melashu Balew Shiferaw; Molla Abebe; Bamlaku Enawgaw
Journal:  J Diabetes Metab Disord       Date:  2018-08-09

3.  High risk of coagulopathy among Type-2 Diabetes Mellitus clients at a municipal hospital in Ghana.

Authors:  Richard Kd Ephraim; Yaw A Awuku; Patrick Adu; Lord Tw Ampomah; Prince Adoba; Solomon Panford; Jerry Pk Ninnoni; Hope Agbodzakey
Journal:  Ghana Med J       Date:  2017-09

4.  Diabetes mellitus is associated with shortened activated partial thromboplastin time and increased fibrinogen values.

Authors:  Ying Zhao; Jie Zhang; Juanwen Zhang; Jianping Wu
Journal:  PLoS One       Date:  2011-01-28       Impact factor: 3.240

5.  Association of coagulation profile with microvascular complications and glycemic control in type 2 diabetes mellitus - a study at a tertiary care center in Delhi.

Authors:  Charu Agarwal; Kashish Bansal; Mukta Pujani; Kanika Singh; Varsha Chauhan; Deepshikha Rana; Shveta Lukhmana
Journal:  Hematol Transfus Cell Ther       Date:  2018-06-11

6.  Coagulopathy and its associated factors among patients with a bleeding diathesis at the University of Gondar Specialized Referral Hospital, Northwest Ethiopia.

Authors:  Melak Aynalem; Elias Shiferaw; Yemataw Gelaw; Bamlaku Enawgaw
Journal:  Thromb J       Date:  2021-06-01

7.  A new in vivo model using a dorsal skinfold chamber to investigate microcirculation and angiogenesis in diabetic wounds.

Authors:  Stefan Langer; Christian Beescho; Andrej Ring; Olivia Dorfmann; Hans Ulrich Steinau; Nick Spindler
Journal:  GMS Interdiscip Plast Reconstr Surg DGPW       Date:  2016-02-18
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.